Hmmm. good question.
Maybe its suggesting that they can bring some of the stage 2 components forward into stage 1.5 to enable the "pontential" of 600k tpa which would align with the "stage 2 synergies identified" tick in the box.
So in essence spending stage 2 money in stage 1.5 which the total outgoing in terms of $ remains the same across the two stages.
- Forums
- ASX - By Stock
- CXM
- New Broker Research
CXM
centrex limited
Add to My Watchlist
0.00%
!
1.7¢

New Broker Research, page-117
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.74M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CXM (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online